Prashant Pokhriyal

home / authors / prashant-pokhriyal

Prashant Pokhriyal is associate scientist at Intas Pharmaceuticals Ltd. (Biopharma Division), Ahmedabad, Gujarat, India.

Articles

Kateryna_Kon/Stock.adobe.com – The business impact of modeling and simulation tools is not well understood and requires clarification of their benefits to drug development.

Do Modeling and Simulation Tools Really Benefit the Biosimilar Industry?

Mili Pathak;Prashant Pokhriyal;Ronak Patel;Laxmi Adhikary
July 2nd 2022

The business impact of modeling and simulation tools is not well understood and requires clarification of their benefits to drug development.

Site Logo

Using Modeling to Improve Data Analytics for Upstream Bioprocessing Workflows

Prashant Pokhriyal;Prateek Gupta;Sridevi Khambhampaty;Rajesh Ullanat;Mili Pathak
February 9th 2022

Recent trends in data analytics highlight the use of modeling techniques to improve process control and monitoring in biopharmaceutical production.

Sergey/Stock.Adobe.com—Modeling techniques can improve process control and monitoring in biopharmaceutical production.

Recent Trends in Data Analytics for Upstream Process Workflows

Prashant Pokhriyal;Prateek Gupta;Sridevi Khambhampaty;Rajesh Ullanat;Mili Pathak
January 2nd 2022

Modeling techniques can improve process control and monitoring in biopharmaceutical production.

Latest Updated Articles

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: November 15th 2024 | Updated: November 21st 2024
Solving Challenges with AAV Aggregate Analysis Using a Novel Size Exclusion Particle to Determine CQAs
Published: October 28th 2024 | Updated: November 21st 2024
Cell-based phenotypic screening with Incucyte® Live-Cell Analysis Systems
Optimizing cGMP Facility Design Space with a Hybrid Approach
Published: October 22nd 2024 | Updated: November 21st 2024
Optimizing cGMP Facility Design Space with a Hybrid Approach
Published: October 28th 2024 | Updated: November 21st 2024
Quantifying Chemotherapeutic Cytotoxicity in Glial Cells using AI-Driven Label-Free Cell Analysis
© 2024 MJH Life Sciences

All rights reserved.